Cipla acquires Inzpera to enhance pediatric healthcare portfolio
after close1 source ↓written by the desknot a recommendation
- in Inzpera Healthsciences
- 100% stake
- Inzpera Healthsciences
- ₹110.65 crore
Cipla has acquired a 100% stake in Inzpera Healthsciences for ₹110.65 crore, marking its entry into the pediatric care segment. This strategic move aims to strengthen its specialty portfolio and address the rising demand for pediatric products in India. Inzpera specializes in gastrointestinal, respiratory, and nutritional support for children, aligning with Cipla's long-term growth strategy.
Not investment advice. For informational purposes only.